Cargando…

Strategies for HCC target discovery

Detalles Bibliográficos
Autores principales:	Molina-Sánchez, Pedro, Lujambio, Amaia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425115/ https://www.ncbi.nlm.nih.gov/pubmed/28455974 http://dx.doi.org/10.18632/aging.101233

Ejemplares similares

Iron overload and liver cancer
por: Molina-Sánchez, Pedro, et al.
Publicado: (2019)

The usual SASPects of liver cancer
por: Lujambio, Amaia, et al.
Publicado: (2015)

AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma
por: Elmas, Abdulkadir, et al.
Publicado: (2022)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Molecular network of HCC aggressiveness
por: Kim, Sang Geon, et al.
Publicado: (2015)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Uncovering the role of USP54 in cancer
por: Miguela, Veronica, et al.
Publicado: (2017)

Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)

HNRNPM Regulates HCC Tumorigenesis and Cancer Stemness: Identification of a Novel Therapeutic Target?
por: Kennedy, Lindsey
Publicado: (2022)

The Endless Sources of Hepatocellular Carcinoma Heterogeneity
por: Barcena-Varela, Marina, et al.
Publicado: (2021)

Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?
por: Negri, Francesca, et al.
Publicado: (2021)

Therapeutic Strategies in HCC: Radiation Modalities
por: Gallicchio, R., et al.
Publicado: (2016)

Protein-Targeting Drug Discovery
por: Vicidomini, Caterina, et al.
Publicado: (2023)

NAFLD as a risk factor for HCC: new rules of engagement?
por: Masuzaki, Ryota, et al.
Publicado: (2016)

ZEB1 Fuels Serine Metabolism to Promote HCC Metastasis
por: Chan, For-Fan, et al.
Publicado: (2023)

Drug Discovery Targeting COVID-19
por: Spicer, Timothy P.
Publicado: (2020)

Discovery of a hydrogen molecular target
por: Sun, Xuejun, et al.
Publicado: (2022)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

Tumor-Intrinsic Mechanisms Regulating Immune Exclusion in Liver Cancers
por: Lindblad, Katherine E., et al.
Publicado: (2021)

Novel Targets and Mechanisms in Antimicrobial Drug Discovery
por: Tondi, Donatella
Publicado: (2021)

HIF2α Activation in NASH: A New Force Pushing Toward HCC
por: Clavería-Cabello, Alex, et al.
Publicado: (2021)

Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022?
por: Wong, Jeffrey Sum Lung, et al.
Publicado: (2023)

PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation
por: Olaizola, Paula, et al.
Publicado: (2023)

Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery
por: Petrizzo, Annacarmen, et al.
Publicado: (2016)

Status of, and strategies for improving, adherence to HCC screening and surveillance
por: Francica, Giampiero, et al.
Publicado: (2019)

New opportunities for kinase drug repurposing and target discovery
por: Knapp, Stefan
Publicado: (2018)

Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes
por: Jang, Jae-Woo, et al.
Publicado: (2016)

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
por: Pascut, Devis, et al.
Publicado: (2020)

Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)

Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery
por: Honoré, Bent, et al.
Publicado: (2021)

Manipulating and tracking single hepatocyte behavior during mouse liver regeneration by performing hydrodynamic tail vein injection
por: Wang, Shuang, et al.
Publicado: (2021)

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
por: Bahra, Marcus, et al.
Publicado: (2023)

Calcium Regulates HCC Proliferation as well as EGFR Recycling/Degradation and Could Be a New Therapeutic Target in HCC
por: Modica, Teresa Maria Elisa, et al.
Publicado: (2019)

The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
por: Ren, Yin-Xiang, et al.
Publicado: (2022)

Frontiers in New Drug Discovery: From Molecular Targets to Preclinical Trials
por: Aminin, Dmitry
Publicado: (2023)

Bacteriophage Bioengineering: A Transformative Approach for Targeted Drug Discovery and Beyond
por: Cui, Longzhu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l9ldf0v81rqdid00r465loiabi